| HOME >> BIOLOGY >> TECHNOLOGY |
Both InSure Quik F I T and InSure FIT are manufactured by Enterix Inc. Physicians can purchase the new InSure Quik F I T point-of-care test from Enterix Inc. and HemoCue, Inc., which distributes the test. The laboratory services for the InSure FIT test are provided by Quest Diagnostics, and collection kits for the InSure FIT test can be obtained from Quest Diagnostics. Both HemoCue and Enterix are companies owned by Quest Diagnostics. For more information, call 800-531-3681.
About Colorectal Cancer
Colorectal cancer, which refers to cancer of the colon and rectum, is expected to have caused approximately 52,000 deaths in the U.S. in 2007. Patients with colorectal cancer detected in its earliest stage have a 90 percent chance of five-year survival. Although guidelines from the American Cancer Society (ACS) recommend that all men and women of average risk should begin regular screening at 50 years of age or older, a recent study found that only about one in four patients receiving Medicare received guideline-based follow-up screening between 1998 and 2004. Screening methods include colonoscopy, once every ten years, as well as flexible sigmoidoscopy, double-contrast barium enema and FOBTs.
About Enterix Inc.
Enterix Inc., a Quest Diagnostics Company, is a U.S.-based
biotechnology company founded in 1997. Enterix manufactures, markets, and
distributes a leading-edge product for colorectal cancer screening called
InSure(R), a fecal immunochemical test (FIT) that is a useful screening aid
fo
'/>"/>
| SOURCE Quest Diagnostics Copyright©2008 PR Newswire. All rights reserved |